Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05999188Recruiting

Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC)

Role: collaborator

NCT05965362Recruiting

Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）

Role: collaborator

NCT06141538Not Yet Recruiting

Response of Intracardiac Thrombus to Anticoagulants in Patients With Non-valvular Atrial Fibrillation (LYSIS)

Role: collaborator

NCT05694273Not Yet Recruiting

Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation

Role: collaborator

NCT05965375Not Yet Recruiting

Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias

Role: collaborator

NCT05967546Not Yet Recruiting

Deep Learning for Intelligent Identification of Arrhythmias

Role: collaborator

NCT05613491Not ApplicableUnknown

Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients

Role: collaborator

NCT02982655Not ApplicableCompleted

Controlling Hypertension After Severe Cerebrovascular Event

Role: collaborator

All 8 trials loaded